| Endocrine and metabolic changes in women with polycystic ovaries and with polycystic ovary syndrome | ||
|---|---|---|
| Prev | Next | |
The thesis is based on the following articles, which are referred to in the text by their Roman numerals:
I Koivunen R, Laatikainen T, Tomás C, Huhtaniemi I, Tapanainen J & Martikainen H (1999) The prevalence of polycystic ovaries in healthy women. Acta Obstetricia et Gynecologica Scandinavica 78: 137-141.
II Tapanainen J, Koivunen R, Fauser B, Taylor A, Clayton R, Rajkhowa M, White D, Franks S, Anttila L, Pettersson K & Huhtaniemi I (1999) A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. Journal of Clinical Endocrinology & Metabolism 84: 1711-1715.
III Koivunen R, Juutinen J, Vauhkonen I, Ruokonen A & Tapanainen J (2001) Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with history of gestational diabetes. Journal of Clinical Endocrinology & Metabolism 86: 2591-2599.
IV Koivunen R, Morin-Papunen L, Ruokonen A, Tapanainen J & Martikainen H. (2001) Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin. Manuscript in press, Human Reproduction.